Which footnotes in the MCG (Milliman Care Guidelines) criteria for pneumonia (M-282) provide additional information on managing antibiotic-resistant organisms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

MCG Pneumonia (M-282) Footnotes for Antibiotic-Resistant Organisms

I cannot provide a definitive answer to this question because the provided evidence does not contain the actual MCG (Milliman Care Guidelines) document M-282 for pneumonia with its specific footnotes [E], [J], [K], or [D].

What the Evidence Does Contain

The evidence provided consists of:

  • Clinical practice guidelines from the American Thoracic Society, Infectious Diseases Society of America, and British Thoracic Society addressing community-acquired pneumonia (CAP), hospital-acquired pneumonia (HAP), and ventilator-associated pneumonia (VAP) 1, 2, 1, 3, 1, 4

  • Praxis Medical Insights summaries of antibiotic regimens for CAP, including coverage for drug-resistant pathogens 5, 6

  • Research studies on antimicrobial resistance patterns, including drug-resistant Streptococcus pneumoniae (DRSP), methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and multidrug-resistant organisms 7, 8, 9, 10, 11

Information on Antibiotic-Resistant Organisms in Pneumonia

While I cannot identify which MCG footnotes address resistant organisms, the evidence extensively covers this topic:

  • Drug-resistant Streptococcus pneumoniae (DRSP) is addressed with recommendations for high-dose amoxicillin, respiratory fluoroquinolones, or third-generation cephalosporins 1, 4

  • MRSA coverage requires vancomycin or linezolid in patients with specific risk factors including prior MRSA infection, recent hospitalization with IV antibiotics, post-influenza pneumonia, or cavitary infiltrates 3, 5

  • Pseudomonas aeruginosa requires antipseudomonal β-lactams (piperacillin-tazobactam, cefepime, carbapenems) plus ciprofloxacin/levofloxacin or aminoglycosides in patients with structural lung disease, recent hospitalization, or prior P. aeruginosa isolation 3, 5

  • Multidrug-resistant gram-negative organisms including extended-spectrum β-lactamase (ESBL) producers are increasingly common in healthcare-associated pneumonia 8, 9, 11

Recommendation

To answer your specific question about MCG M-282 footnotes, you must access the actual MCG criteria document, as this proprietary guideline is not included in the evidence provided.

References

5
Guideline

Antibiotic Regimen Recommendations for Community-Acquired Pneumonia in Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

6
Guideline

Cefepime Dosing for Ventilator-Associated Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7
Research

Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of beta-lactam-resistant Streptococcus pneumoniae.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002

Related Questions

What is the recommended antibiotic treatment for Streptococcus pneumoniae infections?
What is the most appropriate antibiotic treatment for a patient with a Streptococcus pneumoniae infection, given the antibiotic sensitivity results and considering the site and severity of the infection, as well as potential allergies to penicillin or other beta-lactam antibiotics?
For a patient with pneumonia requiring broad‑spectrum empiric therapy, how does vancomycin plus piperacillin‑tazobactam (Zosyn) compare to cefepime plus metronidazole (flag) in terms of antimicrobial coverage and appropriate use?
Is cefepime combined with doxycycline an appropriate empiric regimen for a hospitalized patient with pneumonia?
Is Keflex (Cephalexin) effective for treating pneumonia, what is the recommended adult dose, and is it safe during lactation?
What is the recommended approach for using Zyprexa (olanzapine) in a patient with Parkinson's disease who is experiencing psychotic symptoms?
Which medication is most likely to exacerbate Chronic Obstructive Pulmonary Disease (COPD) in a patient with neuropathy pain, when considering duloxetine, amitriptyline, and gabapentin for treatment?
What is the evidence-based treatment for an 11-year-old child with anxiety and emotional dysregulation?
What is the effect of cocaine on gamma-aminobutyric acid (GABA) in the brain?
What is the proper administration protocol for intravenous (IV) Carbazochrome in a patient, considering their medical history and potential interactions with other medications?
What is the optimal day to use a home influenza (flu) and coronavirus disease 2019 (COVID-19) combo test after symptoms start in a patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.